Receptor Tyrosine Kinase Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
EXEL | B | Exelixis, Inc. | 2.24 | |
KALA | C | Kala Pharmaceuticals, Inc. | 3.74 | |
BPMC | C | Blueprint Medicines Corporation | -2.56 |
Related Industries: Biotechnology
Related ETFs - A few ETFs which own one or more of the above listed Receptor Tyrosine Kinase stocks.
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
IDNA | F | iShares Genomics Immunology and Healthcare ETF | 8.22 | |
CANC | F | Tema Oncology ETF | 6.98 | |
PBE | C | PowerShares Dynamic Biotech & Genome | 6.77 | |
FBT | C | First Trust Amex Biotech Index Fund | 4.51 | |
BBP | C | BioShares Biotechnology Products Fund | 3.75 |
Compare ETFs
Date | Stock | Title |
---|---|---|
Nov 21 | EXEL | 3 Reasons Growth Investors Will Love Exelixis (EXEL) |
Nov 20 | EXEL | Zacks.com featured highlights Amazon, Maplebear, Exelixis and Doximity |
- Receptor Tyrosine Kinase
Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. Of the 90 unique tyrosine kinase genes identified in the human genome, 58 encode receptor tyrosine kinase proteins.
Receptor tyrosine kinases have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Mutations in receptor tyrosine kinases lead to activation of a series of signalling cascades which have numerous effects on protein expression. Receptor tyrosine kinases are part of the larger family of protein tyrosine kinases, encompassing the receptor tyrosine kinase proteins which contain a transmembrane domain, as well as the non-receptor tyrosine kinases which do not possess transmembrane domains.
Popular Now
Recent Comments
- TraderMike on BOOT
- Dr_Duru on BOOT
- TraderMike on Stochastic Reached Oversold
- SuccessfulGrasshopper897 on Stochastic Reached Oversold
- Cos3 on Adding float as advanced filter criteria?
From the Blog
Featured Articles